-
King Pharmaceuticals Research and Development, Inc. et al v. SICOR Inc. et al DC
- 1:05-cv-00337
- D. Del.
- Judge: Sue L. Robinson
- Filed: 05/26/2005
- Closed: 10/29/2007
- Latest Docket Entry: 10/09/2008
- PACER
- Docket updated daily
3
Plaintiffs
4
Defendants
1
Accused
Product
1
Patent-in-Suit
887
Days in
Litigation
-
King Pharmaceuticals Research and Development, Inc. et al v. SICOR Inc. et al DC
- 1:05-cv-00337
- D. Del.
- Judge: Sue L. Robinson
- Filed: 05/26/2005
- Closed: 10/29/2007
- Latest Docket Entry: 10/09/2008
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
17 |
A method of detecting the presence and assessing the severity of coronary artery disease in a human comprising the steps of: (a) administering by an intravenous route to said human about 20 mcg/kg/minute to about 200 mcg/kg/minute of an adenosine
view more
|
Enforceable and Valid
Entry 161 |
18 |
The method of claim 17 wherein said adenosine receptor agonist is administered by intravenous infusion in a dosage of about 140 mcg/kg/minute.
|
Enforceable and Valid
Entry 161 |
23 |
The method of claim 17, 19 or 18, wherein said adenosine receptor agonist is adenosine.
|
Enforceable and Valid
Entry 161 |
43 |
A method of detecting the presence and assessing the severity of coronary artery disease in a human comprising the steps of: (a) administering to said human by intravenous infusion about 20 mcg/kg/minute to about 200 mcg/kg/minute of adenosine in
view more
|
Enforceable and Valid
Entry 161 |